New anti-cancer immunotherapy drug: Fewer side effects, more therapeutic
Unlike conventional cancer drugs that attack and kill cancer cells directly, anti-cancer immunothera...
UCL scientists identify new immunotherapy to combat hepatitis B virus
Scientists at UCL have identified a new immunother...
FDA approves immunotherapy for dMMR endometrial cancer
The anti-programmed death receptor 1 (PD-1) monoth...
Immunotherapy alone extended life for metastatic lung cancer patients with KRAS mutation
Real-word evidence is suggesting, for the first ti...
After 24 Years, Doc Fired by Hospital. Local Uproar Followed.
For 24 years, Thomas Weiner, MD, worked as a medic...
Anthracycline-Free Neoadjuvant Regimen Safe, Effective for TNBC
For patients with triple-negative breast cancer (T...
Engineered safety switch curbs severe side effects of CAR-T immunotherapy
UNC Lineberger Comprehensive Cancer Center researc...
Pegilodecakin No Aid to FOLFOX in Metastatic Pancreatic Cancer
NEW YORK (Reuters Health) – Adding immunothe...
The unveiling of a novel mechanism of resistance to immunotherapy targeting HER2
Immunotherapy continues to show exciting promise i...
Get a load of ZIF! Better delivery of cancer immunotherapy
An antibody loaded onto a porous metal organic fra...